Endocrinology Clinical Trials

  • Home
  • Endocrinology Clinical Trials
Epcoritamab-CAR T Cells for Large B-cell Lymphomas
Conditions: Lymphoma, Non-Hodgkin; Relapsed Diffuse Large B Cell Lymphoma; Refractory Diffuse Large B-cell Lymphoma; High-grade B-cell Lymphoma; Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma

Interventions: Drug: Epcoritamab

Sponsors: Abramson Cancer Center at Penn Medicine; Genmab

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Conditions: Triple Negative Breast Cancer

Interventions: Drug: ProAgio Dose Levels (DL) 1,2,3,4; Drug: ProAgio Dose Expansion

Sponsors: ProDa BioTech, LLC; Emory University; Georgia State University

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 16, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Inspiratory Muscle Training in Postmenopausal Women

Conditions: Postmenopausal Symptoms; Aging; Obesity
Interventions: Device: PrO2 Fit (IMT Trainer)
Sponsors: Indiana University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
TRICAV-II Pivotal: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation.

Conditions: Tricuspid Regurgitation; Tricuspid Valve Disease
Interventions: Device: TricValve® Transcatheter Bicaval Valve System; Drug: Optimal medical therapy
Sponsors: P+F Products + Features USA Inc.; Meditrial USA Inc.
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Effects of an Overground Propulsion Neuroprosthesis in Community-dwelling Individuals After Stroke

Conditions: Stroke
Interventions: Device: Propulsion Neuroprosthesis
Sponsors: Boston University Charles River Campus; Harvard University
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Statin Reminders for Improving Prescribing in Primary Care

Conditions: Cholesterol, Elevated; Clinical Decision Support; Education
Interventions: Other: Interruptive Reminder; Other: Non-interruptive Reminder; Other: No Reminder
Sponsors: Vanderbilt University Medical Center
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Conditions: Biliary Tract Cancer; Breast Cancer; Cervical Cancer; Colon Cancer; Endometrial Cancer; Esophageal Cancer; Gastric Cancer; GastroEsophageal Cancer; Head and Neck Cancer; Hepatocellular Cancer; Non-small Cell Lung Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Thyroid Cancer

Interventions: Drug: MDX2001

Sponsors: ModeX Therapeutics, An OPKO Health Company

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2024Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Pilot Brief Communal Coping Intervention for Adults With Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2
Interventions: Behavioral: Communal Coping Intervention
Sponsors: Carnegie Mellon University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Virtual Diabetes Group Visits Across Health Systems

Conditions: T2DM (Type 2 Diabetes Mellitus); Hypertension; Heart Disease Chronic; Stroke; Hyperlipidemias; Peripheral Vascular Diseases; Obesity
Interventions: Behavioral: Virtual Group Visit
Sponsors: University of Chicago; Advocate Health Care; ACCESS Community Health Network; National Institute on Minority Health and Health Disparities (NIMHD); Midwest Clinicians’ Network
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer

Conditions: Metastatic Pancreatic Cancer
Interventions: Drug: Azeliragon
Sponsors: Cantex Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine